Literature DB >> 10373216

Enhanced blood pressure variability in eNOS knockout mice.

H M Stauss1, A Gödecke, R Mrowka, J Schrader, P B Persson.   

Abstract

It has been shown previously that endogenous nitric oxide can buffer arterial blood pressure variability in dogs and rats. In these former studies, all isoforms of the nitric oxide synthase were blocked pharmacologically and an increased blood pressure variability was observed. Thus the question as to which isoform of the nitric oxide synthase is responsible for the blood pressure buffering effect of endogenous nitric oxide remains unraveled. In the present study, we therefore compared blood pressure variability in knockout mice that lack specifically the gene for endothelial nitric oxide synthase with their respective wild-type controls. One day after carotid artery cannulation, blood pressure was recorded in these conscious mice. During resting conditions, blood pressure variability was markedly enhanced in knockout mice compared with wild-type mice (10.5+/-1.5 mm Hg2 vs 6.0+/-0.8 mm Hg2, P<0.05). Power spectral analysis revealed that this increase in blood pressure variability is manifested at low frequencies that range from 0.05 to 0.40 s-1 (Hz) (5.1+/-1.0 mm Hg2 vs 2.5+/-0.5 mm Hg2, P<0.05). On the basis of these results, we conclude that the blood pressure buffering effect of endogenous nitric oxide is mediated by the endothelial isoform of the nitric oxide synthase. In addition, endothelial nitric oxide is most effective in buffering blood pressure oscillations at frequencies that range from 0.05 to 0.40 s-1 (Hz) in conscious mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373216     DOI: 10.1161/01.hyp.33.6.1359

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

Review 1.  The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.

Authors:  David D Roberts; Thomas W Miller; Natasha M Rogers; Mingyi Yao; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

2.  Cholinergic control of the cerebral vasculature in humans.

Authors:  J W Hamner; Can Ozan Tan; Yu-Chieh Tzeng; J Andrew Taylor
Journal:  J Physiol       Date:  2012-10-15       Impact factor: 5.182

Review 3.  Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms.

Authors:  Joy N Jones Buie; Jim C Oates
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

4.  Epigenetics of Cardiovascular Disease - A New "Beat" in Coronary Artery Disease.

Authors:  Paul J Turgeon; Aravin N Sukumar; Philip A Marsden
Journal:  Med Epigenet       Date:  2014-04

5.  Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.

Authors:  Robrecht Thoonen; Patrick Y Sips; Kenneth D Bloch; Emmanuel S Buys
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

6.  Activation of the STAT1 Pathway Accelerates Periodontitis in Nos3-/- Mice.

Authors:  W Wei; X Xiao; J Li; H Ding; W Pan; S Deng; W Yin; L Xue; Q Lu; Y Yue; Y Tian; M Wang; L Hao
Journal:  J Dent Res       Date:  2019-08       Impact factor: 6.116

Review 7.  The role of NOS in heart failure: lessons from murine genetic models.

Authors:  Imran N Mungrue; Mansoor Husain; Duncan J Stewart
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

Review 8.  Blood pressure regulation VIII: resistance vessel tone and implications for a pro-atherogenic conduit artery endothelial cell phenotype.

Authors:  Jaume Padilla; Nathan T Jenkins; M Harold Laughlin; Paul J Fadel
Journal:  Eur J Appl Physiol       Date:  2013-07-17       Impact factor: 3.078

9.  The role of shear-induced transforming growth factor-β signaling in the endothelium.

Authors:  Tony E Walshe; Nathaniel G dela Paz; Patricia A D'Amore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-22       Impact factor: 8.311

10.  Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression.

Authors:  Carie S Facemire; Andrew B Nixon; Robert Griffiths; Herbert Hurwitz; Thomas M Coffman
Journal:  Hypertension       Date:  2009-08-03       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.